Bullock G, Collins G, Adams R, Thigpen C, Shanley E
Int J Sports Phys Ther. 2023; 18(1):253-261.
PMID: 36793581
PMC: 9897041.
DOI: 10.26603/001c.57680.
Gue Y, Bisson A, Bodin A, Herbert J, Lip G, Fauchier L
Eur J Clin Invest. 2022; 52(6):e13754.
PMID: 35113450
PMC: 9285743.
DOI: 10.1111/eci.13754.
van der Meer D, Kramer I, van Maaren M, van Diest P, Linn S, Maduro J
Int J Cancer. 2020; 148(9):2289-2303.
PMID: 33252836
PMC: 8048677.
DOI: 10.1002/ijc.33417.
Vu Hong T, Nguyen Ba D, Skoog L, Ta Thanh V, Tani E
Cancer Control. 2019; 26(1):1073274819865279.
PMID: 31343899
PMC: 6659192.
DOI: 10.1177/1073274819865279.
Buddeke J, Gernaat S, Bots M, van den Bongard D, Grobbee D, Vaartjes I
BMJ Open. 2019; 9(5):e022664.
PMID: 31152022
PMC: 6549609.
DOI: 10.1136/bmjopen-2018-022664.
Discrepancies between Canadian cancer research funding and site-specific cancer burden: a spotlight on ten disease sites.
Coronado A, Finley C, Badovinac K, Han J, Niu J, Rahal R
Curr Oncol. 2018; 25(5):338-341.
PMID: 30464683
PMC: 6209562.
DOI: 10.3747/co.25.4230.
Sexual quality of life evaluation after treatment among women with breast cancer under 35 years old.
Blouet A, Zinger M, Capitain O, Landry S, Bourgeois H, Seegers V
Support Care Cancer. 2018; 27(3):879-885.
PMID: 30116944
DOI: 10.1007/s00520-018-4374-z.
Trends in incidence, mortality and survival in women with breast cancer from 1985 to 2012 in Granada, Spain: a population-based study.
Baeyens-Fernandez J, Molina-Portillo E, Pollan M, Rodriguez-Barranco M, Del Moral R, Arribas-Mir L
BMC Cancer. 2018; 18(1):781.
PMID: 30068302
PMC: 6090958.
DOI: 10.1186/s12885-018-4682-1.
rs11615 polymorphism increases susceptibility to breast cancer: a meta-analysis of 4547 individuals.
Li B, Shi X, Yuan Y, Peng M, Jin H, Qin D
Biosci Rep. 2018; 38(3).
PMID: 29752341
PMC: 6013698.
DOI: 10.1042/BSR20180440.
Evolution of quality of life in patients with breast cancer during the first year of follow-up in Morocco.
Traore B, El Fakir S, Charaka H, Benaicha N, Najdi A, Zidouh A
BMC Cancer. 2018; 18(1):109.
PMID: 29402232
PMC: 5800277.
DOI: 10.1186/s12885-018-4008-3.
Assessing predicted age-specific breast cancer mortality rates in 27 European countries by 2020.
Cleries R, Rooney R, Vilardell M, Espinas J, Dyba T, Borras J
Clin Transl Oncol. 2017; 20(3):313-321.
PMID: 28726040
DOI: 10.1007/s12094-017-1718-y.
Cancer Control in Central and Eastern Europe.
La Vecchia C, Conte P
Oncologist. 2016; 21(10):1161-1162.
PMID: 27401889
PMC: 5061535.
DOI: 10.1634/theoncologist.2016-0230.
[Place of surgery in the treatment of breast cancer in women at University Hospital Yalgado Ouedraogo: about 81 cases].
Zongo N, Millogo-Traore T, Bagre S, Bague A, Ouangre E, Zida M
Pan Afr Med J. 2016; 22:117.
PMID: 26848364
PMC: 4733492.
DOI: 10.11604/pamj.2015.22.117.6929.
Diagnostic performance of the automated breast volume scanner: a systematic review of inter-rater reliability/agreement and meta-analysis of diagnostic accuracy for differentiating benign and malignant breast lesions.
Meng Z, Chen C, Zhu Y, Zhang S, Wei C, Hu B
Eur Radiol. 2015; 25(12):3638-47.
PMID: 25916389
DOI: 10.1007/s00330-015-3759-3.
Potential for improvement in cancer management: reducing mortality in the European Union.
La Vecchia C, Rota M, Malvezzi M, Negri E
Oncologist. 2015; 20(5):495-8.
PMID: 25888268
PMC: 4425394.
DOI: 10.1634/theoncologist.2015-0011.
Incidence of breast cancer in fars province, southern iran: a hospital-based study.
Mehrabani D, Almasi A, Farahmand M, Ahrari Z, Rezaianzadeh A, Mehrabani G
World J Plast Surg. 2015; 1(1):16-21.
PMID: 25734039
PMC: 4344961.
Convergence with SEER database achieved by a breast cancer network: a longitudinal benchmark of 5-year relative survival.
Jacke C, Albert U, Reinhard I, Kalder M
J Cancer Res Clin Oncol. 2014; 141(6):1109-18.
PMID: 25512079
DOI: 10.1007/s00432-014-1879-9.
Women's participation in breast cancer screening in France--an ethical approach.
Moutel G, Duchange N, Darquy S, Montgolfier S, Papin-Lefebvre F, Jullian O
BMC Med Ethics. 2014; 15:64.
PMID: 25127662
PMC: 4151080.
DOI: 10.1186/1472-6939-15-64.
HER-3 expression in HER-2-amplified breast carcinoma.
Czopek J, Pawlega J, Fijorek K, Puskulluoglu M, Rozanowski P, Okon K
Contemp Oncol (Pozn). 2014; 17(5):446-9.
PMID: 24596534
PMC: 3934027.
DOI: 10.5114/wo.2013.38564.
How breast cancer survivors cope with fear of recurrence: a focus group study.
de Vries J, Den Oudsten B, Jacobs P, Roukema J
Support Care Cancer. 2013; 22(3):705-12.
PMID: 24193220
DOI: 10.1007/s00520-013-2025-y.